José María
Moraleda Jiménez
José María Moraleda Jiménez-rekin lankidetzan egindako argitalpenak (12)
2021
-
Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard- And high-risk myeloma
Blood, Vol. 137, Núm. 1, pp. 49-60
2020
-
Measurable Residual Disease by Next-Generation Flow Cytometry in Multiple Myeloma
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 38, Núm. 8, pp. 784-792
2004
1997
-
BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: Analysis of efficacy, toxicity and prognostic factors
Bone Marrow Transplantation, Vol. 20, Núm. 6, pp. 451-458
1991
-
Clinico-hematological characteristics of acute transformation of chronic myeloproliferative syndromes
Medicina clínica, Vol. 97, Núm. 10, pp. 369-372
-
The value of the immunological subtypes and individual markers compared to classical parameters in the prognosis of acute lymphoblastic leukemia
Hematological Oncology, Vol. 9, Núm. 1, pp. 33-42
1990
-
Non-traumatic rupture of the spleen in malignant hemopathies. 2 new cases
Sangre, Vol. 35, Núm. 6, pp. 477-479
-
Surface phenotype and immunoglobulin levels in B-cell chronic lymphocytic leukaemia.
Haematologia, Vol. 23, Núm. 1, pp. 49-56
1985
-
Immunological markers of peripheral blood and lymph node lymphocytes in Hodgkin's disease
Neoplasma, Vol. 32, Núm. 2, pp. 191-198
1984
-
Biphenotypic leukemia in treated Hodgkin's disease.
Journal of clinical pathology
-
Fenotipos inmunológicos de las leucemias linfoblásticas agudas y sus correlaciones clínico-biológicas.
Sangre, Vol. 29, Núm. 5, pp. 849-860
1983
-
Infecciones en mieloma múltiple.
Revista Clinica Espanola, Vol. 168, Núm. 4, pp. 247-248